Logo image of SMLR

SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis

USA - NASDAQ:SMLR - US81684M1045 - Common Stock

25.035 USD
-1.43 (-5.39%)
Last: 11/3/2025, 1:35:22 PM
Fundamental Rating

5

Taking everything into account, SMLR scores 5 out of 10 in our fundamental rating. SMLR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While SMLR has a great profitability rating, there are quite some concerns on its financial health. SMLR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
In the past 5 years SMLR has always been profitable.
Each year in the past 5 years SMLR had a positive operating cash flow.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

With an excellent Return On Assets value of 7.09%, SMLR belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
With an excellent Return On Equity value of 9.66%, SMLR belongs to the best of the industry, outperforming 84.66% of the companies in the same industry.
The Return On Invested Capital of SMLR (0.92%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 9.02%.
The last Return On Invested Capital (0.92%) for SMLR is well below the 3 year average (20.14%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.09%
ROE 9.66%
ROIC 0.92%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

SMLR's Profit Margin of 86.20% is amongst the best of the industry. SMLR outperforms 98.94% of its industry peers.
SMLR's Profit Margin has improved in the last couple of years.
SMLR has a better Operating Margin (12.16%) than 79.37% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
SMLR's Gross Margin of 90.91% is amongst the best of the industry. SMLR outperforms 97.88% of its industry peers.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
Industry RankSector Rank
OM 12.16%
PM (TTM) 86.2%
GM 90.91%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
SMLR has more shares outstanding than it did 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.08 indicates that SMLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
SMLR has a better Altman-Z score (2.08) than 61.38% of its industry peers.
The Debt to FCF ratio of SMLR is 7.90, which is on the high side as it means it would take SMLR, 7.90 years of fcf income to pay off all of its debts.
SMLR's Debt to FCF ratio of 7.90 is fine compared to the rest of the industry. SMLR outperforms 74.60% of its industry peers.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
SMLR's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. SMLR outperforms 55.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 7.9
Altman-Z 2.08
ROIC/WACC0.11
WACC8.75%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.60 indicates that SMLR may have some problems paying its short term obligations.
With a Current ratio value of 0.60, SMLR is not doing good in the industry: 92.06% of the companies in the same industry are doing better.
A Quick Ratio of 0.58 indicates that SMLR may have some problems paying its short term obligations.
SMLR has a Quick ratio of 0.58. This is amonst the worse of the industry: SMLR underperforms 91.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.58
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 201.43% over the past year.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.17% yearly.
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.40%.
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%

3.2 Future

SMLR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -29.01% yearly.
Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 2.98, the valuation of SMLR can be described as very cheap.
SMLR's Price/Earnings ratio is rather cheap when compared to the industry. SMLR is cheaper than 98.41% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.11, SMLR is valued rather cheaply.
SMLR is valuated quite expensively with a Price/Forward Earnings ratio of 306.80.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SMLR indicates a somewhat cheap valuation: SMLR is cheaper than 65.61% of the companies listed in the same industry.
SMLR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.55.
Industry RankSector Rank
PE 2.98
Fwd PE 306.8
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

SMLR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 64.02% of the companies in the same industry.
SMLR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 78.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.12
EV/EBITDA 84.86
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
SMLR's earnings are expected to decrease with -29.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%

0

5. Dividend

5.1 Amount

SMLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (11/3/2025, 1:35:22 PM)

25.035

-1.43 (-5.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-06 2025-11-06
Inst Owners71.06%
Inst Owner Change0.98%
Ins Owners4.93%
Ins Owner Change0.32%
Market Cap379.03M
Revenue(TTM)42.98M
Net Income(TTM)37.05M
Analysts82.22
Price Target76.84 (206.93%)
Short Float %29.27%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.72%
PT rev (3m)-23.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)150%
EPS NY rev (1m)118.9%
EPS NY rev (3m)107.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.65%
Valuation
Industry RankSector Rank
PE 2.98
Fwd PE 306.8
P/S 8.82
P/FCF 31.12
P/OCF 30.42
P/B 0.99
P/tB N/A
EV/EBITDA 84.86
EPS(TTM)8.41
EY33.59%
EPS(NY)0.08
Fwd EY0.33%
FCF(TTM)0.8
FCFY3.21%
OCF(TTM)0.82
OCFY3.29%
SpS2.84
BVpS25.32
TBVpS-7.49
PEG (NY)N/A
PEG (5Y)0.12
Graham Number69.22
Profitability
Industry RankSector Rank
ROA 7.09%
ROE 9.66%
ROCE 1.08%
ROIC 0.92%
ROICexc 0.95%
ROICexgc N/A
OM 12.16%
PM (TTM) 86.2%
GM 90.91%
FCFM 28.34%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3Y32.01%
ROICexgc growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 7.9
Debt/EBITDA 16.92
Cap/Depr 60.82%
Cap/Sales 0.65%
Interest Coverage 250
Cash Conversion 218.98%
Profit Quality 32.88%
Current Ratio 0.6
Quick Ratio 0.58
Altman-Z 2.08
F-Score3
WACC8.75%
ROIC/WACC0.11
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
Revenue Next Year-43.54%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-342.47%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%

SEMLER SCIENTIFIC INC / SMLR FAQ

What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SMLR.


What is the valuation status for SMLR stock?

ChartMill assigns a valuation rating of 5 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.


How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?

SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 9 / 10.


What is the valuation of SEMLER SCIENTIFIC INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SEMLER SCIENTIFIC INC (SMLR) is 2.98 and the Price/Book (PB) ratio is 0.99.